Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Profound Medical develops MRI-guided, incision-free therapeutic systems for minimally invasive ablation of diseased tissue, primarily targeting prostate conditions and uterine fibroids. Its flagship products, TULSA-PRO and Sonalleve, utilize real-time MRI, focused ultrasound, and thermal feedback to deliver precise, customizable treatments. Serving global markets, the company offers solutions that aim to improve clinical outcomes, reduce side effects, and enable outpatient procedures in urology and gynecology.
This description was generated via AI from an annual report. Updated about 1 year ago.